August 30, 2018

Circulating tumor DNA may predict outcomes in aggressive lymphoma

“Patients with favorable results for both molecular response and interim PET had excellent outcomes,” the researchers wrote. “In contrast, the combination of a positive interim PET scan and no molecular response identified a group of patients at extremely high risk for treatment failure.” {read more here}